VIDA Diagnostics is a leader in quantitative pulmonary image analysis for the diagnosis and treatment of pulmonary diseases. The FDA-cleared Pulmonary Workstation 2.0 (PW2) is the leading lung analysis tool for COPD, emphysema and asthma. Participating in the emerging pulmonary device market that is expected to grow to nearly $3.8 billion by 2011, VIDA’s vision is to establish lung quantitative CT methods as the standard of care for diagnosis and staging of chronic lung disease.